Is Jubilant Ingrevia (JUBLINGREA) overvalued or fairly valued?

MarketChacha shows Jubilant Ingrevia's valuation in context — a forward P/E of about 24.7, a price-to-book of about 3.8 — alongside its revenue and profit growth and whether reported profit converts into operating cash, so you can judge value for yourself. MarketChacha does not issue ratings, price targets, or buy/sell advice.

What is Jubilant Ingrevia's revenue?

Jubilant Ingrevia reported revenue of ₹4,388 Cr for FY2026, with net profit of ₹278 Cr, per official filings.

What is the share price of Jubilant Ingrevia (JUBLINGREA)?

Jubilant Ingrevia last traded at ₹743.75 (+0.9% on the day), as of 7/22/2026 — a delayed quote shown for education, not investment advice.

Jubilant Ingrevia

JUBLINGREA · NSE · Chemicals · India

₹743.75+0.9%

Delayed · as reported by Yahoo Finance · as of Jul 22, 2026, 10:00 AM

Snapshot

TickerJUBLINGREA

ExchangeNSE

SectorChemicals

IndustrySpecialty Chemicals

CountryIndia

HeadquartersNoida, India

Market cap₹11,730 Cr

P/B3.8

Volume48.87L

Websitejubilantingrevia.com

Filings tracked0

About Jubilant Ingrevia

Jubilant Ingrevia Limited engages in life science products and solutions in India, the United States, Europe, China and internationally. The company operates in three segments: Specialty Chemicals, Nutrition & Health Solutions, and Chemical Intermediates. The Specialty Chemicals segment offers bio-pyridine and -picolines, fine chemicals, agro chemicals, custom development and manufacturing services, and microbial control solutions. The Nutrition & Health Solutions segment provides nutrition and health ingredients; and animal and human nutrition health solutions. The Chemical intermediates segment offers acetyls and specialty ethanol. In addition, it provides vitamins, mineral premixes, stress regulator, amino acid, herbal choline, herbal non-antibiotic growth promoter and egg quality enhancer, toxin binder, acidifiers, and enzymes and emulsifiers. The company serves pharmaceutical, nutrition, agrochemical, consumer, and industrial sectors. The company was formerly known as Jubilant LSI Limited and changed its name to Jubilant Ingrevia Limited in October 2020. Jubilant Ingrevia Limited was incorporated in 2019 and is headquartered in Noida, India.

Profile as reported by Yahoo Finance.

Who owns it

Promoters50.9%
Institutions28.2%
Public & other20.9%

45 institutional holders

As reported by Yahoo Finance. Promoter pledge is not included here — that comes from exchange shareholding filings.

Forensic scorecard

No major accounting red flags in the fundamentals we have — profit is backed by cash and returns look healthy.

Net margin trend6.4% → 6.3%

Margin has held broadly steady over the period — stable profitability.

Growth qualityrev -3% · PAT -3%

Profit growth is broadly tracking revenue growth — the earnings trend looks operational rather than one-off.

Computed by MarketChacha from reported figures (Yahoo Finance). Education, not a rating or recommendation.

What's expected next

Next fiscal year

Rev ₹5,825 Cr · EPS 30.09

Est. earnings growth +22.9%

Analyst consensus estimates — not the company's own guidance. As reported by Yahoo Finance.

₹537.3052-wk range₹845.55

Delayed · as reported by Yahoo Finance

New to these terms?

P/E ROE ROCE Margins Market cap

Browse the Learn hub →

Financials at a glance

Source: Yahoo Finance

Annual

Quarterly · last 4

Market cap

₹11,730 Cr

Day change

+0.9%

Fwd P/E

24.7

P/B

3.8

Div yield

0.65%

Beta

0.29

Revenue (FY2026)

₹4,388 Cr

Net margin

6.3%

Revenue CAGR (3y)

-2.8%

Profit CAGR (3y)

-3.3%

Net profit (FY2026)

₹278 Cr

Market figures: Delayed · as reported by Yahoo Finance. Financials as reported in company filings.

Ask MarketChacha about JUBLINGREA

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

Financials

Yearly

Period	Revenue	Net profit	Net margin
FY2026	₹4,388 Cr	₹278 Cr	6.3%
FY2025	₹4,178 Cr	₹251 Cr	6.0%
FY2024	₹4,136 Cr	₹183 Cr	4.4%
FY2023	₹4,773 Cr	₹308 Cr	6.4%

Quarterly

Period	Revenue	Net profit	Net margin
2026Q2	₹1,300 Cr	₹106 Cr	8.1%
2026Q1	₹1,179 Cr	₹86 Cr	7.3%
2025Q4	₹1,051 Cr	₹47 Cr	4.5%
2025Q3	₹1,121 Cr	₹69 Cr	6.2%

Figures as reported, in ₹ (crore). Source: Yahoo Finance.

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed · as reported by yahoo finance) are delayed and shown for reference only. Verify with the linked sources before acting.